#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The succesfull treatment of follicular lymphomarelaps performed by 90Y Ibritumomab tiuxetan (Zevalin)


Authors: J. Slabý 1;  T. Kozák 1;  O. Bělohlávek 2;  O. Lang 3
Authors‘ workplace: Oddělení klinické hematologie, FNKV, Praha, 2PET centrum, Nemocnice Na Homolce, Praha, 3Oddělení nukleární medicíny, FNKV, Praha 1
Published in: Transfuze Hematol. dnes,, 2004, No. 3, p. 112-113.
Category:

Overview

Radioimmunotherapy represents the other step in specific anti-tumor therapy. 57-years old womanreceived Ytrium 90 ibritumomab tiuxetan (Zevalin) as a treatment of relaps of follicular lymphoma.Treatment was tolerated very well; it was followed by uncomplicated trombocytopenia (Gr. 3, WHOclassification) andneutropenia (Gr. 2,WHOclassification).PET-CT evaluationperformed after finishingof treatment revealed achievement of complete remission.

Key words:
radioimmunotherapy, Ytrium 90 ibritumomab tiuxetan, follicular lymphoma

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
Haematology Internal medicine Clinical oncology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#